Deep Brain Stimulation for Movement Disorders

Total Page:16

File Type:pdf, Size:1020Kb

Deep Brain Stimulation for Movement Disorders Deep Brain Stimulation for Movement Disorders Overview Deep brain stimulation (DBS) is a surgical procedure to implant a pacemaker-like device that sends electrical signals to brain areas responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator/battery device. Similar to a heart pacemaker, a neurostimulator uses electric pulses to help regulate brain activity. DBS can help reduce the symptoms of tremor, slowness of movement, stiffness, and walking problems caused by movement disorders. It may be a treatment option for people who have Parkinson’s disease, dystonia, or essential tremor and whose symptoms are not well controlled with medication. Successful DBS allows people to better manage their symptoms, reduce their medications, and improve their quality of life. What is deep brain stimulation? In deep brain stimulation, electrodes are placed in a specific area of the brain (usually the subthalamic nucleus) depending on the symptoms being treated. The electrodes are placed on both the left and right sides of the brain through small holes made at the top of the skull. The electrodes are connected by long extension wires that are passed Figure 1. Overview of a deep brain stimulator (DBS). under the skin and down the neck to a battery- Electrodes are placed deep within the brain through small holes in the skull. The electrodes are connected by an powered stimulator under the skin of the chest (Fig. extension wire to a battery-powered stimulator placed 1). When turned on, the stimulator sends electrical under the skin of the chest. Because the left side of the pulses to block the faulty nerve signals causing brain controls the right side of the body and vice versa, tremors, rigidity, and other symptoms. DBS is commonly performed on both sides of the brain. A deep brain stimulator system has three parts that are implanted inside the body: The patient uses a handheld controller to turn the DBS system on and off. The doctor programs the • Neurostimulator – a programmable battery- stimulator settings with a wireless device. The powered pacemaker device that creates electric stimulation settings can be adjusted as a patient’s pulses. It is placed under the skin of the chest condition changes over time. Unlike other surgeries, below the collarbone or in the abdomen. such as pallidotomy or thalamotomy, DBS does not • Lead – a coated wire with a number of damage the brain tissue. Thus, if better treatments electrodes at the tip that deliver electric pulses develop in the future, the DBS procedure can be to the brain tissue. It is placed inside the brain reversed. and connects to an extension wire through a small hole in the skull. DBS is very effective at reducing dyskinesias, the uncontrolled wiggling movements caused by high • Extension – an insulated wire that connects the lead to the neurostimulator. It is placed doses of levadopa medication. Typically, DBS will under the skin and runs from scalp, behind the help make your symptoms less severe so that lower ear, down the neck, and to the chest. medication doses may be used. > 1 Electro des can be placed in the following brain areas (Fig 2): • Subthalamic nucleus (STN) – effective for tremor, slowness, rigidity, dystonia and dyskinesia. Most commonly used to treat Parkinson’s disease. • Thalamus (VIM) – effective for tremor. It is often used to treat essential tremor. • Globus pallidus (GPi) – effective for tremor, slowness, rigidity, dystonia and dyskinesia. It is used to treat dystonia and Parkinson’s disease. Who is a candidate? You may be a candidate for DBS if you have: • a movement disorder with debilitating symptoms (tremor, stiffness) and your medications have begun to lose effectiveness. • troubling “off” periods when your medication wears off before the next dose can be taken. • troubling “on” periods when you develop Figure 2. A cross section of the brain. Normal muscle medication-induced dyskinesias (excessive tone, movement, timing, and coordination depend on wiggling of the torso, head, and/or limbs). complex electrical circuits or feedback loops in the brain. The basal ganglia are responsible for activating and DBS may not be an option if you have severe inhibiting these feedback loops. untreated depression, advanced dementia, or if you In Parkinson’s disease, parts of the basal ganglia are have symptoms that are not typical for Parkinson’s either under- or over-stimulated. Normal movement is disease. replaced by tremor, rigidity and stiffness. DBS of specific ganglia alters the abnormal electrical circuits and helps DBS can help treat many of the symptoms caused stabilize the feedback loops, thus reducing symptoms. by the following movement disorders: with multiple physicians, nurses, and surgeons. The • Parkinson’s disease: tremor, rigidity, and team discusses the best treatment plan for each slowness of movement caused by the death of patient. If the team agrees that you are a good dopamine-producing nerve cells responsible for candidate for DBS, you will be contacted to relaying messages that control body movement. schedule an appointment with a neurosurgeon. • Essential tremor: involuntary rhythmic tremors of the hands and arms, occurring both at rest and during purposeful movement. Also Who performs the procedure? may affect the head in a “no-no” motion. Deep brain stimulation surgery is performed by a • Dystonia: involuntary movements and neurosurgeon who has specialized training in prolonged muscle contraction, resulting in functional neurosurgery. The surgical team also twisting or writhing body motions, tremor, and includes a neurologist. abnormal posture. May involve the entire body, or only an isolated area. Spasms can often be The surgical decision suppressed by “sensory tricks,” such as Seek treatment at a medical center that offers a touching the face, eyebrows, or hands. team approach and the full range of treatment options including medication, surgery, and A team of specialists including a neurologist, rehabilitation (physical, exercise, voice, balance). neuropsychologist, and neurosurgeon will evaluate your condition to determine if surgery is an option. The timing of when to consider DBS surgery is Your thinking and memory, current medications, different for each patient. If you have severe motor and general health will be evaluated. You will be disability despite optimal medications, then surgery videotaped performing a variety of movements should be considered. DBS should not be thought of (walking, finger tap, rising from a chair) while on as a last resort. As Parkinson’s disease progresses, and off medication. Your symptoms and abilities are DBS is no longer an option if your symptoms don’t measured using the Unified Parkinson Disease respond to medication, or if you are severely Rating Scale (UPDRS). disabled even in the best “on” state. And unlike other surgeries (pallidotomy, thalamotomy) that After your evaluation and videotaping is complete, damage brain tissue, DBS is reversible and can be your case will be discussed at a monthly conference turned off or removed if necessary. > 2 The surgery is performed in two stages. Stage 1 is implantation of the electrodes in the brain. About one week later, Stage 2 is performed. This includes implantation of the stimulator device in the chest and tunneling of the wires to the neck. What happens before surgery? You will typically undergo tests (e.g., blood test, electrocardiogram, chest X-ray) several days before surgery. An MRI scan of your brain will be performed. In the doctors office you will sign consent forms and complete paperwork to inform the surgeon about your medical history, including allergies, medicines, anesthesia reactions, and previous surgeries. Stop taking all non-steroidal anti-inflammatory medicines (Naprosyn, Advil, Motrin, Nuprin, Aleve, etc.) 1 week before surgery. Stop smoking, chewing tobacco, and drinking alcohol 1 week before and 2 weeks after surgery because these Figure 3. A stereotactic frame is attached to the activities can cause bleeding problems. You may patient’s head with four pins. also need to have clearance from your primary care physician or cardiologist if you have a history of other medical or heart conditions. No food or drink, including your Parkinson’s medication, is permitted a fter midnight the night before surgery. Try to get a good night’s sleep. The DBS surgery involves multiple steps and lasts most of the day, during which you will be awake and off medication. Morning of surgery • Shower using antibacterial soap. Dress in freshly washed, loose-fitting clothing. • Wear flat-heeled shoes with closed backs. • If you have instructions to take regular medication the morning of surgery, do so with small sips of water. • Remove make-up, hairpins, contacts, body piercings, nail polish, etc. • Leave all valuables and jewelry at home (including wedding bands). • Bring a list of medications (prescriptions, over- the-counter, and herbal supplements) with dosages and the times of day usually taken. • Bring a list of allergies to medication or foods. Arrive at the hospital 2 hours before your scheduled Figure 4. A skin incision (dashed line) is made across the surgery time to complete the necessary paperwork top of the patient’s head. Two small burr holes (circles) and pre-procedure work-ups. An anesthesiologist are drilled in the skull to pass the electrode into the brain. will talk with you and explain the effects of anesthesia and its risks. An intravenous (IV) line will be placed in your arm. Step 1: attach stereotactic frame The procedure is performed stereotactically, which What happens during surgery? requires attaching a frame to your head. While you For stage 1, implanting the electrodes in the brain, are seated, the frame is temporarily positioned on the entire process lasts 5 to 7 hours. The surgery your head with Velcro straps. The four pin sites are generally lasts 3 to 4 hours. injected with local anesthesia to minimize discomfort.
Recommended publications
  • Neural Circuit and Clinical Insights from Intraoperative Recordings During Deep Brain Stimulation Surgery
    brain sciences Perspective Neural Circuit and Clinical Insights from Intraoperative Recordings During Deep Brain Stimulation Surgery Anand Tekriwal 1,2,3 , Neema Moin Afshar 2, Juan Santiago-Moreno 3, Fiene Marie Kuijper 4, Drew S. Kern 1,5, Casey H. Halpern 4, Gidon Felsen 2 and John A. Thompson 1,5,* 1 Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO 80203, USA 2 Department of Physiology and Biophysics, University of Colorado School of Medicine, Aurora, CO 80203, USA 3 Medical Scientist Training Program, University of Colorado School of Medicine, Aurora, CO 80203, USA 4 Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA 5 Department of Neurology, University of Colorado School of Medicine, Aurora, CO 80203, USA * Correspondence: [email protected] Received: 28 June 2019; Accepted: 18 July 2019; Published: 20 July 2019 Abstract: Observations using invasive neural recordings from patient populations undergoing neurosurgical interventions have led to critical breakthroughs in our understanding of human neural circuit function and malfunction. The opportunity to interact with patients during neurophysiological mapping allowed for early insights in functional localization to improve surgical outcomes, but has since expanded into exploring fundamental aspects of human cognition including reward processing, language, the storage and retrieval of memory, decision-making, as well as sensory and motor processing. The increasing use of chronic neuromodulation, via deep brain stimulation, for a spectrum of neurological and psychiatric conditions has in tandem led to increased opportunity for linking theories of cognitive processing and neural circuit function. Our purpose here is to motivate the neuroscience and neurosurgical community to capitalize on the opportunities that this next decade will bring.
    [Show full text]
  • Brain-Machine Interface: from Neurophysiology to Clinical
    Neurophysiology of Brain-Machine Interface Rehabilitation Matija Milosevic, Osaka University - Graduate School of Engineering Science - Japan. Abstract— Long-lasting cortical re-organization or II. METHODS neuroplasticity depends on the ability to synchronize the descending (voluntary) commands and the successful execution Stimulation of muscles with FES was delivered using a of the task using a neuroprosthetic. This talk will discuss the constant current biphasic waveform with a 300μs pulse width neurophysiological mechanisms of brain-machine interface at 50 Hz frequency via surface electrodes. First, repetitive (BMI) controlled neuroprosthetics with the aim to provide transcranial magnetic stimulation (rTMS) intermittent theta implications for development of technologies for rehabilitation. burst protocol (iTBS) was used to induce cortical facilitation. iTBS protocol consists of pulses delivered intermittently at a I. INTRODUCTION frequency of 50 Hz and 5 Hz for a total of 200 seconds. Functional electrical stimulation (FES) neuroprosthetics Moreover, motor imagery protocol was used to display a can be used to applying short electric impulses over the virtual reality hand opening and closing sequence of muscles or the nerves to generate hand muscle contractions movements (hand flexion/extension) while subject’s hands and functional movements such as reaching and grasping. remained at rest and out of the visual field. Our work has shown that recruitment of muscles using FES goes beyond simple contractions, with evidence suggesting III. RESULTS re-organization of the spinal reflex networks and cortical- Our first results showed that motor imagery can affect level changes after the stimulating period [1,2]. However, a major challenge remains in achieving precise temporal corticospinal facilitation in a phase-dependent manner, i.e., synchronization of voluntary commands and activation of the hand flexor muscles during hand closing and extensor muscles [3].
    [Show full text]
  • NEUROSURGICAL FOCUS Neurosurg Focus 49 (1):E6, 2020
    NEUROSURGICAL FOCUS Neurosurg Focus 49 (1):E6, 2020 Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation J. Blair Price, PhD,1 Aaron E. Rusheen, BSc,1,2 Abhijeet S. Barath, MBBS,1 Juan M. Rojas Cabrera, BSc,1 Hojin Shin, PhD,1 Su-Youne Chang, PhD,1 Christopher J. Kimble, MA,3 Kevin E. Bennet, PhD, MBA,1,3 Charles D. Blaha, PhD,1 Kendall H. Lee, MD, PhD,1,4 and Yoonbae Oh, PhD1,4 1Department of Neurologic Surgery, 2Medical Scientist Training Program, 3Division of Engineering, and 4Department of Biomedical Engineering, Mayo Clinic, Rochester, Minnesota The development of closed-loop deep brain stimulation (DBS) systems represents a significant opportunity for innova- tion in the clinical application of neurostimulation therapies. Despite the highly dynamic nature of neurological diseases, open-loop DBS applications are incapable of modifying parameters in real time to react to fluctuations in disease states. Thus, current practice for the designation of stimulation parameters, such as duration, amplitude, and pulse frequency, is an algorithmic process. Ideal stimulation parameters are highly individualized and must reflect both the specific disease presentation and the unique pathophysiology presented by the individual. Stimulation parameters currently require a lengthy trial-and-error process to achieve the maximal therapeutic effect and can only be modified during clinical visits. The major impediment to the development of automated, adaptive closed-loop systems involves the selection of highly specific disease-related biomarkers to provide feedback for the stimulation platform. This review explores the disease relevance of neurochemical and electrophysiological biomarkers for the development of closed-loop neurostimulation technologies.
    [Show full text]
  • Deep Brain Stimulation for Chronic Pain: Time to Reconsider the Skeptical Attitude?
    brain sciences Editorial Deep Brain Stimulation for Chronic Pain: Time to Reconsider the Skeptical Attitude? Konstantin V. Slavin 1,* , Emil D. Isagulayn 2 and Dzhamil A. Rzaev 3,4 1 Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA 2 Department of Functional Neurosurgery, Federal State Autonomous Institution, N.N. Burdenko National Scientific and Practical Center for Neurosurgery of the Ministry of Healthcare of the Russian Federation, 125047 Moscow, Russia; [email protected] 3 Federal Center of Neurosurgery, 630087 Novosibirsk, Russia; [email protected] 4 Institute of Medicine and Psychology, Novosibirsk State University, 630090 Novosibirsk, Russia * Correspondence: [email protected] Received: 19 October 2020; Accepted: 22 October 2020; Published: 23 October 2020 Despite continuous advancements in systematic treatment of chronic pain there is still a subset of clinical conditions where the standard medical and surgical approaches are not uniformly effective. Moreover, in addition to these relatively rare but remarkably treatment-refractory diagnoses (post-stroke pain, brachial plexus avulsion pain, spinal cord injury pain, anesthesia dolorosa, etc.), there are many other, much more prevalent, conditions (persistent spinal pain syndrome (previously referred to as failed back surgery syndrome), painful peripheral neuropathy, complex regional pain syndromes, etc.) where even a small percentage of treatment-refractory patients constitutes a large group of chronic pain sufferers. The treatment algorithms for these patients include gradual escalation of various modalities, usually chosen based on efficacy and safety, with treatment invasiveness being interpreted as direct measure of surgical risks and complications. The latter argument (on significant treatment-related risks) has been a deterrent for widespread acceptance of certain surgical interventions and a major source of reluctance for many pain-treating specialists and patients alike.
    [Show full text]
  • Deep Brain Stimulation for Epilepsy: an Update
    Deep Brain Stimulation for Epilepsy: an Update Claudio Pollo1 and Kaspar Schindler2 1 Neurosurgery and 2 Neurology Departments, University Hospital Bern, Inselspital, Bern Summary Keywords: Deep brain stimulation, epilepsy, anterior nu- cleus, centro-median nucleus, hippocampus, closed-loop Deep brain stimulation (DBS) has shown efficacy in stimulation achieving significant seizure reduction in patients with refractory epilepsy not suitable for resective surgery. Based on the identification of several cortico-subcor- Tiefe Hirnstimulation bei Epilepsie: ein Update tical networks involved in epilepsy, several anatomi- cal targets have been proposed for different epileptic Die Tiefe Hirnstimulation (THS) erzielt eine effek- syndromes. Among these targets, the most exten- tive Reduktion der Anfallshäufigkeit bei Patienten, die sively investigated and also showing the most prom- nicht für resezierende chirurgische Massnahmen geeig- ising results are the anterior nucleus (ANT) as well as net sind. Verschiedene anatomische Zielpunkte wurden the centro-median (CMT) nucleus of the thalamus, and aufgrund der Identifizierung von neuronalen kortikalen the hippocampus (Hipp). This paper provides a review und subkortikalen Netzwerken als Grundlage für unter- of the literature in DBS for epilepsy focused on these schiedliche epileptische Syndrome vorgeschlagen. Unter targets with available data on efficacy as well as side diesen Zielpunkten wurden die anteriore Thalamuskern- effects. Technological advancements like responsive gruppe (ANT), der Nucleus centromedianus (CMT) sowie stimulation (RNS) are also underlined. der Hippokampus (Hipp) umfangreich untersucht und Although promising results were reported for these zeigen dabei zudem die vielversprechendsten Ergebnis- different targets in specific epileptic syndromes, only se. Diese Arbeit liefert einen Literaturüberblick über die ANT and RNS were tested on larger series of patients THS zur Behandlung von Epilepsie mit Augenmerk auf and could reach class I evidence level of efficacy.
    [Show full text]
  • Neuromodulation: Harnessing Neuroplasticity with Brain Stimulation and Rehabilitation
    Neuromodulation: Harnessing Neuroplasticity with Brain Stimulation and Rehabilitation Presenters: Cecília N. Prudente, PT, MS, PhD1 Bernadette T. Gillick, PT, MS, PhD1 Colum MacKinnon, PhD2 Teresa J.Kimberley, PT, PhD1 1Dept. of Rehabilitation Medicine 2Dept. of Neurology Conflicts of interest TJK: consulting income from MicroTransponder Others: Nothing to declare Learning objectives 1. Be familiar with forms of brain stimulation 2. Be able to identify safety and feasibility of each technique 3. Understand the purposes of using the parameters of brain stimulation 4. Translate brain stimulation research into clinical implications Harnessing neuroplasticity to improve motor function 1. Neuromodulation tools 2. Down-regulation 3. Up-regulation 4. Hijacking neural firing patterns 5. Where are we now, where are we going, and how do we get there? 6. Discussion Harnessing neuroplasticity to improve motor function 1. Neuromodulation tools 2. Down-regulation 3. Up-regulation 4. Hijacking neural firing patterns 5. Where are we now, where are we going, and how do we get there? 6. Discussion What is neuromodulation? http://blog.cambridgeconsultants.com/medical-technology/wp- content/uploads/2014/05/Neuromodulation.jpg Publications per year 1200 1000 800 Neuromodulation 600 Neuromodulation & rehabilitation 400 200 0 2016 1978 1988 1998 2008 Source: Pubmed How to neuromodulate? Healthy state Neuroplasticity Injury Medications Neuromodulation Rehabilitation Neuromodulation tools Why neuromodulate? E I Healthy state : greater excitability : greater inhibition
    [Show full text]
  • DBS: Medtronic Electrocautery / Surgery Letter
    Neuromodulation Technical Services US Minneapolis, MN • 800-707-0933 NEUROMODULATION STANDARD LETTER, 8 August 2014 VERSION 2.0 DEEP BRAIN STIMULATION (DBS) SYSTEMS Introduction This standard letter is designed to further explain Medtronic Neuromodulation labeling and is not meant as a substitute for approved labeling. For more information, please refer to the Medtronic® DBS™ Therapy Information for Prescribers (IFP) manual. It is important to note that the terms “cautery”, “electrocautery”, “bovie” and “electrosurgery” are sometimes used interchangeably. These procedures can generate large surgical currents in the body. The objective of this letter is to describe the principles of using surgical procedures involving electrically driven cutting/coagulating surgical tools near/over a DBS system (INS and leads) using the terms “cautery” and “surgical current”. During cautery and electrocautery, current is used to heat probes/electrodes that come in contact with tissue. The current does not usually enter the patient’s body. During electrosurgery, high-frequency current enters the patient’s body, making the patient part of the active circuit. Cautery can be operated in a Bipolar or Monopolar configuration. In Bipolar configuration, two closely spaced electrodes serve as the surgical electrode and return electrode. Surgical current is restricted to a small volume of tissue close to /between the electrode pair. In Monopolar configuration, an electrical circuit is completed between the generator, cables, surgical electrodes and return electrode (aka grounding pad). The surgical current is dispersed from the surgical electrode through the patient to the return electrode completing the path to the cautery generator. The remainder of this document will discuss the factors that impact the possible/alternate paths and directions of “Monopolar dispersed current” when used near/over a DBS system.
    [Show full text]
  • Trends in Clinical Deep Brain Stimulation
    Journal of Clinical Medicine Editorial Special Issue: Trends in Clinical Deep Brain Stimulation Marcus L. F. Janssen 1,2,* and Yasin Temel 2,3 1 Department of Clinical Neurophysiology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands 2 School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands; [email protected] 3 Department of Neurosurgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands * Correspondence: [email protected] Deep brain stimulation (DBS) has been successfully applied in several neurological and psychiatric disorders. A substantial number of patients suffering from a brain disorder either do not, or insufficiently, respond to pharmacological treatment. This results in increasing costs for public health systems and a growing burden for society. Fortunately, the number of approved indications for DBS keeps expanding, thereby improving the quality of life of many individuals. Nevertheless, defining the optimal target and stimulation paradigm for the individual patient remains a challenge. In this Special Issue, a series of twelve papers is presented by international leaders in the field on the current trends in clinical deep brain stimulation for a range of neurological and psychiatric disorders. One of the most common psychiatric disorders considered to be treated using DBS is depression. Unfortunately, recent randomized controlled trials show disappointing results of DBS for treatment-resistant depression (TRD). Contrary to these findings, the meta- analysis conducted by Hitti et al. shows that DBS is an effective treatment for TRD [1]. This promising finding should serve as an encouragement for future studies to optimize patient Citation: Janssen, M.L.F.; Temel, Y.
    [Show full text]
  • Deep Brain Stimulation: Surgical Process
    Deep Brain Stimulation: Surgical Process Kia Shahlaie, MD, PhD Assistant Professor Bronte Endowed Chair in Epilepsy Research Director of Functional Neurosurgery Minimally Invasive Neurosurgery Department of Neurological Surgery University of California, Davis UC Davis Deep Brain Stimulation Program Outline • Brief history • Basal ganglia review – Physiology (rate model) – Parkinson’s disease • DBS Procedure – Step 1: direct, indirect, physiological targeting – Step 2: pulse generator implantation • Postop care and outcomes – Programming – Risks and benefits of DBS UC Davis Deep Brain Stimulation Program Irving Cooper (1922‐1985) • Born in Atlantic City, NJ – Son of a salesman – Worked his way through school • BA, MD, MS, PhD, NSG residency – Faculty at NYU, then NYMC • Pioneer in functional neurosurgery – Anterior choroidal artery ligation… Cooper IS: Parkinsonism: Its Medical and Surgical Therapy. Springfield, Ill: Charles C Thomas, 1961 UC Davis Deep Brain Stimulation Program What do the basal ganglia do? • Scale Movement H Y – amplitude and velocity P E R I D N • Focus Movement I D D R I I E R R – select specific muscles C E E T C C T – suppress antagonist T muscles • Rate Model: Direct: Facilitate “wanted” movements Indirect: Inhibit “unwanted” movements UC Davis Deep Brain Stimulation Program Rate Model THALAMOCORTEX STRIATUM BASAL GANGLIA GPi UC Davis Deep Brain Stimulation Program Rate model explains kinetic disorders Hypokinetic disorders: Hyperkinetic disorders: Parkinson’s disease Dystonia, hemiballism, HD Delong, TINS 1990:13,
    [Show full text]
  • Deep Brain Stimulation for Treatment
    orders & is T D h e n i r a a Lavano et al., Brain Disord Ther 2015, 4:3 p r y B Brain Disorders & Therapy DOI: 10.4172/2168-975X.1000168 ISSN: 2168-975X Review Article Open Access Deep Brain Stimulation for Treatment-Resistant Depression: Review of the Literature Angelo Lavano*, Attilio Della Torre, Giorgio Volpentesta, Giusy Guzzi, Marisa De Rose and Mary Romano Department of Neurosurgery, University “Magna Graecia” of Catanzaro, Italy Abstract Chronic Major depression is one of the most debilitating psychiatric disorders ; 8-13% of patients are treatment resistant. DBS has been applied to the following targets: Subcallosal cingulate gyrus (Brodmann 25a), Ventral Capsule and Ventral Striatum (VC/VS), Nucleus Accumbens (NA), Inferior thalamic Peduncle (ITP) Rostral Cingulate Cortex. In the contrary to neurological diseases, for major depression there is not a single pathological target structure; several brain structures presumably play different roles in the development as well as in the maintenance of symptoms; some targets are in close anatomical or functional relationship (neural networks) and an overlap of effect is plausible; different target might manipulate the pathological network at different nodes. This overview summarizes research on the mechanisms of brain networks with respect to psychiatric diseases and highlights the role of the reward system in DBS for patients with treatment-resistant depression. Keywords: Deep brain stimulation; Major depression; ventral approximately 1.5% of the general population at any one time and is a capsule; ventral striatum; Brodmann area 25; Subgenual cingulate; significant source of worldwide disability. It is defined as a state of extreme Nucleus accumbens sadness or melancholia that affects person’s activities in daily life as well as social functioning.
    [Show full text]
  • Deep Brain and Cortical Stimulation
    UnitedHealthcare® Oxford Clinical Policy Deep Brain and Cortical Stimulation Policy Number: SURGERY 090.23 T2 Effective Date: July 1, 2021 Instructions for Use Table of Contents Page Related Policy Coverage Rationale ....................................................................... 1 • Vagus and External Trigeminal Nerve Stimulation Documentation Requirements ...................................................... 2 Prior Authorization Requirements ................................................ 2 Applicable Codes .......................................................................... 2 Description of Services ................................................................. 3 Clinical Evidence ........................................................................... 4 U.S. Food and Drug Administration ............................................. 6 References ..................................................................................... 6 Policy History/Revision Information ............................................. 8 Instructions for Use ....................................................................... 8 Coverage Rationale Conventional deep brain stimulation is proven and medically necessary for treating the following indications (this does not apply to directional deep brain stimulation): Dystonia Essential Tremor Parkinson’s disease Refractory Epilepsy Responsive cortical stimulation is proven and medically necessary for treating partial or focal seizure disorder. For medical necessity clinical coverage
    [Show full text]
  • Neurobionics and the Brain-Computer Interface: Current Applications And
    Narrative review Neurobionics and the brainecomputer interface: current applications and future horizons Jeffrey V Rosenfeld1,2, Yan Tat Wong3 eurobionics is the science of directly integrating electronics Summary with the nervous system to repair or substitute impaired e e The brain computer interface (BCI) is an exciting advance in Nfunctions. The brain computer interface (BCI) is the linkage neuroscience and engineering. of the brain to computers through scalp, subdural or intracortical In a motor BCI, electrical recordings from the motor cortex of electrodes (Box 1). Development of neurobionic technologies paralysed humans are decoded by a computer and used to requires interdisciplinary collaboration between specialists in drive robotic arms or to restore movement in a paralysed medicine, science, engineering and information technology, and hand by stimulating the muscles in the forearm. large multidisciplinary teams are needed to translate the findings of Simultaneously integrating a BCI with the sensory cortex will high performance BCIs from animals to humans.1 further enhance dexterity and fine control. ’ BCIs are also being developed to: Neurobionics evolved out of Brindley and Lewin s work in the < provide ambulation for paraplegic patients through 1960s, in which electrodes were placed over the cerebral cortex of a controlling robotic exoskeletons; 2-4 blind woman. Wireless stimulation of the electrodes induced < restore vision in people with acquired blindness; — fi phosphenes spots of light appearing in the visual elds. This < detect and control epileptic seizures; and was followed in the 1970s by the work of Dobelle and colleagues, < improve control of movement disorders and memory who provided electrical input to electrodes placed on the visual enhancement.
    [Show full text]